Calvin Chen Sheng

Calvin Chen Sheng

Auto-generated profile, based on publicly available information

Calvin Chen Sheng

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2021 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
CSCalvin C Sheng
Calvin C Sheng
JGJoanna Ghobrial
Joanna Ghobrial
LCLeslie Cho
Leslie Cho
Background: Single coronary artery (SCA) is a rare congenital anomaly where blood to the heart is supplied through a common trunk. Identifying these abnormalities is important because some variants can compromise myocardial blood flow and increase risk of sudden cardiac death. Case summary: We present five patients with varying Lipton Group I and Group II SCA subtypes, corroborated on multi-imaging modalities and evaluated with comprehensive non-invasive as well as invasive testing. Their clinical presentations also vary from a spectrum of asymptomatic finding to angina equivalent. The decision for definitive surgical intervention involving unroofing of the involved vessel depends largely on symptoms and evidence of myocardial ischaemia. Discussion: While SCA findings are often incidental and benign, understanding the origin, branching pattern, and course of the anomalous artery has implications in prognosis and treatment. This usually involves a combination of anatomic assessment with imaging such as coronary Computed Tomography Angiography (CTA), Magnetic Resonance Angiography (MRA), and/or coronary angiography as well as functional assessment with invasive testing using tools like instantaneous wave-free ratio and intravascular ultrasound both at rest and with stress. Individualized treatment plans can then be made through a multidisciplinary approach involving adult congenital heart disease specialists and congenital cardiothoracic surgeons.

24 July 2023 in The American Journal of Cardiology
Verified
Journal Article
Closed access
CSCalvin Chen Sheng
Calvin Chen Sheng
ASAdrian Santini
Adrian Santini
FAFrank H. Annie
Frank H. Annie
MRMuhammad Rawala
Muhammad Rawala
DBDeepak L. Bhatt
Deepak L. Bhatt
ANAravinda Nanjundappa
Aravinda Nanjundappa

3 September 2024 in Structural Heart
Verified
Journal Article
Open access
ZAZade Akras
Zade Akras
NSNabil Sabbak
Nabil Sabbak
CSCalvin C. Sheng
Calvin C. Sheng
JYJames Yun
James Yun
SKSamir R. Kapadia
Samir R. Kapadia
Transcatheter aortic valve replacement (TAVR) has emerged as a viable treatment option for patients with symptomatic aortic stenosis across all surgical risk groups. Although the need for alternative access to transfemoral access is becoming less frequent due to better device profiles, there is a continued need for such options. Common approaches used today include subclavian, carotid, caval, aortic, or apical. However, the transseptal approach has not been described with the current S3 delivery system. We present, to our knowledge, the first reported case of a transseptal TAVR using the standard delivery system and under monitored anesthesia care (MAC). This case demonstrates that advances in maneuverability and device profile make transseptal delivery of the S3 valve a safe and effective approach in some patients with no other peripheral arterial access.

31 August 2023 in Vascular Medicine
Verified
Journal Article
Closed access
CSCalvin C Sheng
Calvin C Sheng
BWBruce L Wilkoff
Bruce L Wilkoff
SLSean P Lyden
Sean P Lyden
ESEdward Soltesz
Edward Soltesz
SCScott J Cameron
Scott J Cameron
ANAravinda Nanjundappa
Aravinda Nanjundappa